<DOC>
	<DOCNO>NCT01190826</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability clinical activity ASM-024 stable moderate asthma .</brief_summary>
	<brief_title>Safety , Tolerability Clinical Activity ASM-024 Stable Moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Able willing provide write informed consent . Male female subject , ≥ 18 year ≤ 55 year age Diagnosis moderate asthma regular inhale corticosteroid without short longacting Beta2agonists FEV1 ≥ 55 % predict absence medication asthma Female subject childbearing potential must negative pregnancy test ( serum betahuman chorionic gonadotropin ( bHCG ) ) Screening , negative pregnancy test immediately administration study drug Periods 1 , 2 3 . Sexually active female nonsterile partner must willing use adequate contraception . Male subject must willing use condom spermicide duration participation study , plus additional 30 day follow study drug administration ensure partner use highly effective method birth control combine oral contraceptive , implant , injectables intrauterine device ( IUD ) . Male subject must ensure female partner willing use adequate contraception . Demonstration increase FEV1 ≥ 10 % predict spirometry perform 1020 minute administration 2 puff 100 microgram salbutamol Screening . Clinically significant condition illness moderate asthma systemic disease Pregnant nursing woman woman intend conceive course study positive serum pregnancy test Screening positive urine pregnancy test study . Women childbearing potential ( unless surgically sterilize hysterectomy bilateral tubal ligation , postmenopausal least two year ) use highly effective method birth control . Nonsurgically sterile male male partner childbearing potential willing use condom spermicide duration participation study plus additional 30 day follow study drug administration ensure partner use highly effective method birth control combine oral contraceptive , implant , injectables IUD . Respiratory tract infection worsen asthma change asthma medication within 6 week Screening/Baseline . Current cigarette smoker former smoker smoke history great 10 pack year stop smoke within 12 month precede enrolment study . Positive urine cotinine test Screening . History illicit drug use alcohol abuse within 12 month Screening . Positive test Hepatitis B , Hepatitis C Human Immunodeficiency Virus ( HIV ) Screening . Any medication know prolong QT / QTc interval . Any following concomitant medication precede administration salbutamol Screening precede administration study drug : Oral i.v . corticosteroid within 1 month ; Inhaled intranasal corticosteroid within 48 hour ; Long act Beta2agonists within 24 hour ; Short act Beta2agonists within 8 hour ; Anticholinergic aerosols within 24 hour ; Theophyllinecontaining product within 48 hour . Use NSAIDs within 7 day precede administration salbutamol Screening throughout study . Use antihistaminic drug within 3 day precede administration salbutamol Screening . Use investigational product participation clinical trial use investigational product within 30 day dose within 90 day case longacting product ( ex . : Depomedrol ) biologics longacting halflife ( ex . : monoclonal antibody ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Stable moderate asthma</keyword>
</DOC>